| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |